ALGS
Aligos Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.02
+5.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 16.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.98x
- Price / sales
- 0.99x
- Price / cash flow
- -0.33x
Enterprise value
- Enterprise value
- $4.5M
- EV / sales
- 0.14x
- EV / EBITDA
- -0.06x
- EV / EBIT
- -0.06x
- Market cap
- $31.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026